Original Article Health Policy
Rethinking emergency department revisits in critically ill adults: the role of high-flow nasal oxygen

Rethinking emergency department revisits in critically ill adults: the role of high-flow nasal oxygen

Authors

Lucas Tanaka

Lucas Tanaka

American University of Beirut Medical Center, Grenada

Clara Haddad

Clara Haddad

St Thomas' Hospital, Georgia

Corresponding
Freya Herrera

Freya Herrera

Singapore General Hospital, Nicaragua

Published

October 22, 2023

Paper ID

PAP-000184

Status

Published

DOI

10.65712/tmj.test000442

Rethinking emergency department revisits in critically ill adults: the role of high-flow nasal oxygen

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: The cost of emergency department revisits to health systems is substantial. Methods: We conducted a case series across 13 centres between 2020 and 2021. Results: Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.56 (95% CI 0.25 to 0.86). Conclusion: Future work should test high-flow nasal oxygen in a pragmatic multicentre trial.

Introduction

emergency department revisits remains a leading cause of avoidable harm among critically ill adults.

Earlier studies of high-flow nasal oxygen were small or single-centre. Practice around high-flow nasal oxygen varies widely between centres.

Earlier studies of high-flow nasal oxygen were small or single-centre. emergency department revisits remains a leading cause of avoidable harm among critically ill adults. Guidelines make only a weak recommendation on high-flow nasal oxygen.

Materials and Methods

The primary outcome was emergency department revisits, assessed blind to allocation.

Analyses were adjusted for age, sex and baseline severity. Eligible participants were critically ill adults.

Results

Effects were consistent across prespecified subgroups.

The adjusted odds ratio was 0.42 (95% CI 0.40 to 0.91). emergency department revisits occurred in 21% of the intervention group versus 34% of controls. The adjusted odds ratio was 0.71 (95% CI 0.40 to 0.60).

Serious adverse events were rare and similar between groups. emergency department revisits occurred in 18% of the intervention group versus 20% of controls.

GroupnEventsRate %
Age ≥ 658013710.5
Age < 655789140.5
Intervention373028.6
TABLE 1: Baseline characteristics
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Change in emergency department revisits
Shown for critically ill adults; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Change in emergency department revisits
Shown for critically ill adults; error bars are 95% confidence intervals.

emergency department revisits occurred in 18% of the intervention group versus 35% of controls. The adjusted odds ratio was 0.84 (95% CI 0.44 to 0.89).

Serious adverse events were rare and similar between groups. emergency department revisits occurred in 4% of the intervention group versus 20% of controls.

Discussion

Future work should test high-flow nasal oxygen in a pragmatic multicentre trial. These findings suggest that high-flow nasal oxygen is associated with better emergency department revisits in critically ill adults. Implementation will depend on staffing, cost and local protocols.

Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.

Implementation will depend on staffing, cost and local protocols. Future work should test high-flow nasal oxygen in a pragmatic multicentre trial.

Conclusions

High-flow nasal oxygen merits wider use for critically ill adults to improve emergency department revisits.

References

1. Costa N, Silva W, et al. Pharmacist-led medication review and surgical site infection. JAMA. 2011;316(3):658-1708.

2. Patel O, Herrera D, et al. Frailty screening and falls. Ann Intern Med. 2014;181(5):865-1734.

3. Nasser O, Volkov J, et al. Nurse-led discharge planning and glycaemic control. Eur Heart J. 2024;343(8):164-1320.

4. Moreau G, Rahman L, et al. Prone positioning and in-hospital mortality. Crit Care Med. 2025;183(10):83-1306.

5. Farouk H, Yilmaz F, et al. SGLT2 inhibitors and medication adherence. Crit Care Med. 2011;254(11):493-1091.

6. Yilmaz L, Farouk I, et al. A sepsis alert system and ventilator-free days. BMJ. 2022;247(1):133-1102.

7. Mensah K, Nakamura B, et al. Tranexamic acid and patient satisfaction. N Engl J Med. 2020;182(7):431-1445.

Appendices

The statistical analysis plan is in the online supplement.